| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
34 |
| Employees |
100 |
| Revenues (TTM) (Millions $) |
39 |
| Net Income (TTM) (Millions $) |
-8 |
| Cash Flow (TTM) (Millions $) |
19 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Pfenex Inc is a biotechnology company that specializes in the development of innovative protein-based therapeutics and vaccines. The company was founded in 2009 by a team of experienced scientists and executives dedicated to advancing the science of protein engineering and expression.
The company's technology platform is based on a proprietary protein expression system that allows for the rapid and cost-effective production of recombinant proteins. This system enables the company to overcome many of the limitations of traditional protein expression systems, including low yields, slow production times, and difficulty in expressing certain types of proteins.
Pfenex Inc's technology is particularly well-suited to the development of complex protein therapeutics, such as those used to treat cancer, autoimmune disorders, and infectious diseases. The company is currently developing a number of novel protein-based therapeutics that have the potential to transform the way these diseases are treated.
One of the key advantages of Pfenex Inc's technology is its ability to produce high-quality proteins that are free of impurities and contaminants. This is due to the company's extensive expertise in protein engineering, purification, and characterization.
In addition to its work on protein therapeutics, Pfenex Inc is also developing a number of vaccine candidates, including a novel vaccine for COVID-19. The company's vaccine technology is based on its proprietary expression system, which allows for the rapid production of large quantities of vaccine antigens.
Pfenex Inc has a strong track record of successful collaborations with leading pharmaceutical and biotechnology companies. The company has partnered with a number of companies to develop protein-based therapeutics and vaccines for a range of diseases.
Overall, Pfenex Inc is a leading player in the field of protein engineering and expression. The company's proprietary technology platform, deep expertise in protein engineering and purification, and strong partnerships make it well-positioned to continue to develop innovative protein-based therapeutics and vaccines that have the potential to transform the lives of patients around the world.
Company Address: 10790 Roselle Street San Diego 92121 CA
Company Phone Number: 352-4400 Stock Exchange / Ticker: NYSEAMER PFNX
|
%